1/133
Looks like no tags are added yet.
parenteral drug delivery
any drug delivery occurring outside of the GIT but typically used for injectable routes of drug delivery
how are drugs unstable in water prepared for parenteral drug delivery?
as a freeze dried powder for dissolution or suspension at the time of injection
how are drugs that are unstable in oxygen packaged for parenteral drug delivery?
packaged in nitrogen & sealed from the air & moisture
If an injectable suspension is formulated, the particles must be very ________
fine
USP name for a drug solution or liquid drug
[drug] injectin
USP name for a solids for dissolution prior to injection
[drug] for injection
USP name for an emulsion with dissolved or dispersed drug
[drug] injectable emulsion
USP name for a suspension of drug solids
[drug] injectable suspension
USP name for a solid for suspension prior to injection
[drug'] fr injectable suspension
intravenous
IV injections are given directly into a vein. Medications can be given in a variety of volumes. This route gives 100% bioavailability and the fastest onset of action.
intramuscular
given into a muscle, slower onset than IV injections, but still fairly rapid onset of action.
Drugs given via IM injection diffuse through the muscle tissue and are absorbed by capillaries within the muscle tissue.
The particular muscle used as the site of injection will control onset of action based upon that muscles’ relative density.
how does muscle density affect parenteral drug absorption?
More dense muscle tissue will result in slower absorption and faster blood flow in a muscle tissue will speed up absorption.
IM injected suspensions will have ________ absorption than solutions as the drug is not yet dissolved.
slower
subcutaneous
also called hypodermic injections, are given under the skin.
SC injectable solutions diffuse to veins in the subcutaneous region, while injectable suspensions must have the drug dissolve first before they absorb
intradermal
ID injections are given into the skin (unlike SC injections which are under the skin).
intrathecal
Intrathecal injections are injections into the intrathecal space of the spinal cord.
intra-spinal
given in the spinal column
intra-arterial
Injection into an artery rather than a vein.
intra-ocular
Injections into the eye, typically to treat a serious eye condition.
intra-cardiac
Injections into the heart, typically in emergency situations.
can oily injections be given IV?
no- oil can cause blood vessel blockages w potential for a fatal pulmonary embolism
can o/w emulsion be given IV?
yes, as long as the internal oil phase droplets are 1um or smaller so that it does not cause blod vessel blockages
additional stringent rules within GMP for injections
must be sterilized as the terminal step in manufacturing and manufactured in as clean an environment as possible.
components of injectable solutions
active ingredient and excipients dissolved in water for injection (WFI).
may have solubilizing agents
solubilizing agents (parenteral)
can be used as needed to improve the solubility or rate of solution of poorly soluble active compounds
The pH of the solution can be adjusted to improve dissolution, however it should be ________ with the tissue it will be injected into (parenteral)
isotonic
during manufacturing, injectables should be formulated in an __________ to lower the final microbial load for sterilization & mitigate endotoxins
ISO 8 class cleanroom
what helps limit cleaning requirements for injection manufacturing?
disposable sterile parts
for cleaning in parenteral manufacturing, what is used for initial and final rinses?
initial = USP purified water
final = USP water for injection (WFI)
can you use detergents in parenteral manufacturing?
no- avoid due to possibility of trace detergent making it into the final product
why must you limit time between washing/drying/sterilizing in parenteral manufacturing?
to prevent microbial growth
siliconization
a thin layer of silicone is added to syringe parts or portions of the packaging in order to improve the smoothness of syringe action. Silicone oil is typically used.
helps to ensure that vials and syringes are completely emptied and the entire dose is dispensed.
what parts are typically siliconized? (parenteral manufacturing)
vials
syringe barrels
stoppers
syringe needles
why are syringes overfilled?
to account for lost dose and siliconization minimizes the amount of overfill needed.
purpose of siliconizing syringe needles?
improve needle insertion
poorly soluble ing can use ________ to help improve mixing & rate of solution in parenteral injections
impellers
when compounding a parenteral solution, it is important to ensure that impeller does not form a ____________ in the solution and lead to trapped air within the soln
vortex
_________ may be used to improve dissolution of excipients/drugs as long as they are stable in the heat
elevated temp
filling of parenteral drugs
Once the bulk solution is prepared, it can be transferred and packaged in containers, typically single dose vials with rubber stoppers or pre-filled syringes.
Following filling, the final solution is then sterilized.
do single or multidose vials have more variability?
single
multidose vials have less significant variability as the variability makes up a smaller part of the whole volume
what are injectable susp used for?
drugs that do not readily dissolve or can be used for extended-release
how are suspensions typically administered?
IM or sometimes SC
what determines rate of absorption for a suspended drug?
rate of dissolution at the injection site
Similar to general pharmaceutical suspensions, particles can settle and may need a _________ to prevent particle caking.
suspending agent
why would you use a wetting agent in an injectable susp?
to ensure that particles are adequately dispersed
additional req for injectable susp
terility
isotonicity
pyrgen free
syringeable
stable over lifetime of product without caking/forming crystals
buffer
are suspensions terminally sterilized?
no— can lead to drug degradation
as suspensions are not terminally sterilized, what happens to them instead?
they are compounded from sterile ing using aseptic technique
what happens if susp particles are too large?
may not easily pass thru 18-21 gauge needle (300-600 um)
can be trapped on the rouge surfaces of the inside of the needle → buildup and clogging of syringe
what causes crystallization of injectable susp?
due to temperature variations during storage as small amounts of drug that dissolve can precipitate and form crystals.
how do susp try to prevent crystal growth?
have excipients designed to prevent it
may have a low conc of suspended particles to prevent crystal formation
why are injectable emulsions less commonly used?
it is hard to get the contained oil droplets smaller than 1 um
when are injectable emulsions commonly used?
for total parenteral nutrition (TPN) for patients who cannot consume food orally
how do emulsions work for TPN?
The oily interior phase allows for delivery of fatty acids and lipophilic nutrients.
caution for use of emulsions and TPN IV lines
oily droplets may coalesce and lead to embolisms
For powder formulations that will be made up into solutions or suspensions at the time of injection, powders are typically compounded…
sterilely as powders can not easily withstand terminal sterilization.
how can drug soln in an organic or non-aq solvent be sterilized? (preparation of sterile drug powder)
sterilized by filtration and then a nonsolvent can be added to cause the drug to precipitate or crystallize out of the solution.
The resulting crystals are sterile and can be used for compounding sterile powders.
powders for injection req solvent to be added at the time of _________ to dissolve the powder and form a soln w/o need for extensive mixing
injection
why is solvent added at time of injection for powder injection?
dissolves powder and forms a soln without need for extensive mixing
diff bw powder for injection and susp
powders for susp forms a susp instead of a soln and req suspending agents
must be able to remain stable across shelf life
utilize surfactants to prevent crystal growth
what do powder for susp use to prevent crystal growth?
surfactants
what happens to freeze dried formulations instead of terminal sterilization?
soln are sterilized by filtration
transferred to sterile packaging containers
freeze dried
temp for freeze drying to be done at
-20 - 40C
to prevent water formation
in freeze-dried formulation, after freeze drying, a second _________ step is used to remove any residual contained ___________
drying / water
why can’t freeze-dried formulations be isotonic?
too much added salt can decrease the temperature required for collapsing and forming the fluffy easily reconstituted solids too much.
why can only limited amt of buffer be used in freeze-dried formulations?
only so much buffer can easily be freeze-dried without losing buffer to the removed water as the solid freeze dries.
special glass vials used for freeze-drying contain __________
lyostoppers
allow sublimated water vapor to escape during freeze drying
packaging of freeze-dried
Special glass vials are used for freeze drying that 4 contain lyostoppers (stoppers for lyophilization or freeze-drying). These vials allow the sublimated water vapor to escape during freeze drying.
Vials with solution are placed in a freeze dryer which is operated at low temperature (-30 to -40C typically).
Once the product freezes, the chamber is placed under vacuum pressure and then heated to sublimate the liquid and leave the lyophilized solid in the vials.
The vials can then be subjected to a drying cycle to remove residual liquid and can be sealed while in the vacuum to prevent outside contamination.
key disadvantage of ER injection
inability to discontinue the medication after the dose is administered. The patient must wait for all of the dose to be released for the drug to clear their system.
Drugs for extended-release injections typically need to be ________ enough to deliver a small quantity injection that contains enough active ingredient for multiple doses over time
potent
req for ER injection drugs
must be potent enough to deliver a mall quantity injection that contains enough active ing for multiple doses over time
not readily metabolized after injection but before rel
must be stable in injectable formulation for duration of its shelf-life & duration of extended time in body
injection site irritation should be limited for the drug/easily managed
all ER injections are considered ______ delivery systems
depot
oily injections
oily solutions with the drug dissolved in a lipophilic solvent and are typically administered as IM or sometimes SC injections.
The oily solution when injected will disperse in the muscle or subcutaneous space and form a depot allowing for extended drug release
implications of partition coefficient for oily injections
the drug should not so greatly favor the oily vehicle that it does not absorb well into the tissues and blood vessels to systemic circulation
oily susp
require the drug to dissolve first prior to absorption slowing the rate of absorption
the drug release will be zero order as the limiting factor in drug absorption is drug dissolution
oily soln
the absorption rate will increase as drug content in the oil decrease
commonly used oils
vegetable oils such as peanut, corn, olive, cottonseed, or sesame oil or synthetic/semi-synthetic oils such as isopropyl myristate, ethyl oleate, and polyethylene glycols (PEGs)
storage for oily injectable formulations
store away from light & heat so oils don’t oxidize
req for oils in oily injections
non-irritant
don’t interact w drug
slowly eliminated from injection site
help to maintain an appropriate rel rate of drug over time
main issue with oily injection
injection site irritation than aqueous suspensions, so many suspensions are becoming more commonly used.
aqueous susp
depot injection formulation, not all are long acting (ex. insulin injections which are administered daily) but can be designed as depot formulation for ER over weeks
how should aqueous suspensions be formulated?
w adding viscosity enhancers to avoid caking to ensure that particles can easily be resuspended after a period of time
what type of viscosity enhancers are particularly useful for aqueous susp?
ones that exhibit thixotropy, in that they are more liquid under shearing forces such as being drawn up and ejected from a syringe, but are more viscous in the vial and at the site of 5 injection.
what happens to aqueous susp after administration?
the aqueous vehicle is absorbed and the particulates are left behind in the muscle or subcutaneous tissue.
microparticulate inj
made up of polymers containing the drug that are slowly degraded from the outside in allowing near zero order drug release over time.
how are polymers selected for microparticulates?
based upon the drug release profile desired
The longer the polymer chain the more ________ the microparticulate will be and the slower the drug will be released
viscous
Drug release is reliant on _________ of portions of the polymer chain making the polymer shorter and releasing drug as the polymer _________
cleavage / degrades
PGLA
lactic acid portion is more hydrophobic than the glycolic acid component.
1 of the most commonly used polymers due to its biocompatibility and release profile
The more lipophilic polymers will _____ water penetration into the microparticulate and therefore will ______ the hydrolysis reactions that cleave and shorten the polymers allowing the drug to be released.
slow / slow
several methods for manufacturing microparticles
emulsion/solvent evaporation
spray drying
spray congealing
phase separation/coacervation
extrusion.
Emulsion/solvent evaporation (manufacturing method)
an o/w emulsion is formed using a volatile oil in the internal phase. The drug and polymer are dissolved in the oil and then the oil can be evaporated from the emulsion to form suspended microparticulates in the aqueous phase. The microparticulates can then be filtered out of the aqueous phase.
This process can be done in several more complex ways including using water in oil in water w/o/w emulsions.
spray drying/congealing (manufacturing method)
utilizes heat to evaporate solvent from a solution or suspension of drug and polymer while spray congealing takes molten drug and polymer and uses cooling to form highly spherical microparticulates using the molten liquid’s surface tension
phase separation/coacervation
polymers can be added to a non-solvent to form a precipitate. Drug can be added to the non-solvent and polymers will wrap around the drug prior to precipitation and adding more non-solvent will form solid particulates
extrusion
the polymer is melted and drug is dispersed into the melted polymer. The melted drug and polymer mixture can be placed in an extruder which maintains the melted phase and forces the material through a die forming strands of material that break up into smaller microparticulates.
Following development of an injectable formulation and packaging of the solution or suspension, the injectable formulation must be sterilized unless…
it is compounded using sterile ingredients with aseptic technique
Sterilization uses the ____________ to describe the relationship between the time of sterilization and the amount of microbes killed
decimal reduction value or D value
D value
the time of sterilization needed to ensure that only 10% of the viable microbes remain
moist heat sterilization (autoclaving)
kills microbes through coagulating and denaturing their proteins. Using moist heat allows the sterilization process to be completed under lower temperatures than those required for dry heat sterilization as the steam generated can penetrate materials.
For moist heat sterilization, the _________ the temperature used the shorter the duration of sterilization.
higher